MEDEC slams Canadian classification regulations
This article was originally published in Clinica
Executive Summary
The emphasis of the proposed regulations to implement the Canadian risk-based classification system for medical devices is on premarket review, claims the Canadian industry association, MEDEC. The Hearn Report recommendation for improved post-market surveillance has been ignored, says Kevin Murray, director of regulatory affairs and communication at MEDEC.